Last reviewed · How we verify
diclofenac 0.1% ophthalmic susp. — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
diclofenac 0.1% ophthalmic susp. (diclofenac 0.1% ophthalmic susp.) — Nemocnice Kolín.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| diclofenac 0.1% ophthalmic susp. TARGET | diclofenac 0.1% ophthalmic susp. | Nemocnice Kolín | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- diclofenac 0.1% ophthalmic susp. CI watch — RSS
- diclofenac 0.1% ophthalmic susp. CI watch — Atom
- diclofenac 0.1% ophthalmic susp. CI watch — JSON
- diclofenac 0.1% ophthalmic susp. alone — RSS
Cite this brief
Drug Landscape (2026). diclofenac 0.1% ophthalmic susp. — Competitive Intelligence Brief. https://druglandscape.com/ci/diclofenac-0-1-ophthalmic-susp. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab